Most powerful obesity drug yet: People lost up to 25% of weight in trial
Next-generation obesity drug Retatrutide is being developed by pharmaceutical giant Eli Lilly, which also makes tirzepatide, a potent dual-acting treatment for obesity (Zepbound) and type 2 diabetes (Mounjaro). Both medications build on GLP-1-based obesity drug […]
